Modified HPLC-ESI-MS Method for Glycated Hemoglobin Quantification Based on the IFCC Reference Measurement Procedure and Its Application for Quantitative Analyses in Clinical Laboratories of China.
BACKGROUND
The level of glycated hemoglobin (HbA1c ) has been recognized as an important indicator of long-term glycemic control. However, the HbA1c measurement is not currently included as a diagnostic determinant in China. Current study aims to assess a candidate modified International Federation of Clinical Chemistry reference method for the forthcoming standardization of HbA1c measurements in China.


METHODS
The HbA1c concentration was measured using a modified high-performance liquid chromatography-electrospray ionization-mass spectrometry (HPLC-ESI-MS) method. The modified method replaces the propylcyanide column with a C18 reversed-phase column, which has a lower cost and is more commonly used in China, and uses 0.1% (26.5 mmol/l) formic acid instead of trifluoroacetic acid. Moreover, in order to minimize matrix interference and reduce the running time, a solid-phase extraction was employed. The discrepancies between HbA1c measurements using conventional methods and the HPLC-ESI-MS method were clarified in clinical samples from healthy people and diabetic patients. Corresponding samples were distributed to 89 hospitals in Beijing for external quality assessment.


RESULTS
The linearity, reliability, and accuracy of the modified HPLC-ESI-MS method with a shortened running time of 6 min were successfully validated. Out of 89 hospitals evaluated, the relative biases of HbA1c concentrations were < 8% for 74 hospitals and < 5% for 60 hospitals. Compared with other conventional methods, HbA1c concentrations determined by HPLC methods were similar to the values obtained from the current HPLC-ESI-MS method.


CONCLUSIONS
The HPLC-ESI-MS method represents an improvement over existing methods and provides a simple, stable, and rapid HbA1c measurement with strong signal intensities and reduced ion suppression.
Beijing Fangshan District Liangxiang Hospital, Beijing, China.
Zhixin
Z
Song
Beijing Fangshan District Liangxiang Hospital, Beijing, China.
Baoyuan
B
Xie
Eye Hospital, China Academy of Chinese Medical Science, Beijing, China.
Huaian
H
Ma
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Rui
R
Zhang
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Pengfei
P
Li
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Lihong
L
Liu
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Yuhong
Y
Yue
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Jianping
J
Zhang
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Qing
Q
Tong
Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. wqt36@163.com.
Qingtao
Q
Wang
D002681:China; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D064790:Clinical Laboratory Services; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006761:Hospitals; D006801:Humans; D016014:Linear Models; D008297:Male; D012016:Reference Values; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*
D006442:Glycated Hemoglobin
diabetes; external quality assessment; glycated hemoglobin; high-performance liquid chromatography; mass spectrometry